Daiken Medical Co., Ltd.

TSE:7775.T

500 (JPY) • At close November 5, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

20232022202120202019201820172016201520142013201220112010200920082007
Revenue 9,750.1669,137.1028,540.4437,861.9698,523.3548,406.6078,585.2768,399.6058,261.4168,033.0547,635.8017,068.356,515.2556,242.3575,739.3695,181.7844,608.452
Cost of Revenue 5,818.8035,606.9414,856.4824,502.8334,789.6714,468.6944,359.1953,991.3773,944.9793,860.3313,711.9333,562.83,354.8793,270.5982,926.9292,646.5152,335.84
Gross Profit 3,931.3633,530.1613,683.9613,359.1363,733.6833,937.9134,226.0814,408.2284,316.4374,172.7233,923.8683,505.553,160.3762,971.7592,812.442,535.2692,272.612
Gross Profit Ratio 0.4030.3860.4310.4270.4380.4680.4920.5250.5220.5190.5140.4960.4850.4760.490.4890.493
Reseach & Development Expenses 249316382448488512532.926479.766447.60943743431100000
General & Administrative Expenses 1,899.7211,78913513314819623325327626926524800000
Selling & Marketing Expenses 3403163062692661,9301,904.5671,936.7321,873.9941,82219030700000
SG&A 2,239.7212,1052,0921,9432,0162,1262,137.5672,189.7322,149.9942,0912,0711,90000000
Other Expenses 6.9182.6744.06839.81620.2531.0221.6736.47613.6936.82314.425-1.19113.166-8.4383.157-39.46-3.221
Operating Expenses 2,488.7212,475.7012,533.0812,437.9192,539.2772,688.3242,720.3182,696.9742,620.4952,550.8942,533.972,244.7832,145.7951,997.4071,977.0121,827.931,743.913
Operating Income 1,442.6421,054.4591,150.878921.2161,194.4051,249.5881,505.7631,711.2531,695.941,621.8271,389.8971,260.7661,014.58974.35835.428707.339528.697
Operating Income Ratio 0.1480.1150.1350.1170.140.1490.1750.2040.2050.2020.1820.1780.1560.1560.1460.1370.115
Total Other Income Expenses Net -6.183-310.45923-5-96-143.282-13.6437.267-20.762-6.939-8.433-12.341-59.065-35.001-85.925-36.783
Income Before Tax 1,436.4591,025.0251,151.337944.751,191.111,153.6721,362.4811,697.611,703.2081,601.0661,382.9591,252.3341,002.24915.287800.427621.414491.916
Income Before Tax Ratio 0.1470.1120.1350.120.140.1370.1590.2020.2060.1990.1810.1770.1540.1470.1390.120.107
Income Tax Expense 447.857312.962320.28269.518331.563302.072350.336451.609549.927503.211501.462464.791598.132360.229312.924251.92174.542
Net Income 988.602712.062831.056675.231859.547851.61,012.1441,246.0011,153.2811,097.854881.497787.543404.108555.058487.503369.494317.373
Net Income Ratio 0.1010.0780.0970.0860.1010.1010.1180.1480.140.1370.1150.1110.0620.0890.0850.0710.069
EPS 34.4124.7928.9323.529.9229.0533.7941.5538.4536.3629.1926.5313.6818.9316.7732.1514.29
EPS Diluted 34.4124.7928.9323.529.9229.0533.7641.538.4136.292926.1713.518.616.3531.3714.29
EBITDA 1,658.791,324.8941,470.5341,217.5481,467.8361,553.6331,759.7671,893.9891,893.9041,783.5011,593.2421,510.4511,330.4361,269.5541,081.012843.024687.826
EBITDA Ratio 0.170.1450.1720.1550.1720.1850.2050.2250.2290.2220.2090.2140.2040.2030.1880.1630.149